Abstract
The recurrence and/or lack of response of certain tumors to radio- and chemotherapy has been attributed to a small subpopulation of cells termed cancer stem cells (CSCs). CSCs have been identified in many tumors (including solid and hematological tumors). CSCs are characterized by their capacity for self-renewal, their ability to introduce heterogeneity within a tumor mass and its metastases, genomic instability, and their insensitivity to both radiation and chemotherapy. The latter highlights the clinical importance of studying this subpopulation since their resistance to traditional treatments may lead to metastatic disease and/or tumor relapse. Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common malignancy worldwide with the highest incidence occurring in East Asia and eastern and southern Africa. Several cellular subpopulations believed to have CSC properties have been isolated from HNSCCs, but at present, identification and characterization of CSCs remains an experimental challenge with no established or standardized protocols in place to confirm their identity. In this review we discuss current approaches to the study of CSCs with a focus on HNSCCs, particularly in the context of what this might mean from a therapeutic perspective.
Abbreviations
- ABC:
-
ATP-binding cassette
- AKT:
-
Protein kinase B
- ALCAM:
-
Activated leukocyte cell adhesion molecule
- ALDH:
-
Aldehyde dehydrogenase
- ATP:
-
Adenosine triphosphate
- BCRP:
-
Breast cancer resistant protein
- BMI1:
-
Moloney murine leukemia virus insertion site 1
- CD44:
-
Cluster of differentiation
- CSC:
-
Cancer stem cell
- EMT:
-
Epithelial-mesenchymal transition
- ESCC:
-
Esophageal squamous cell carcinoma
- FACS:
-
Fluorescence-activated cell sorting
- HIF:
-
Hypoxia-inducible factors
- HNC:
-
Head and neck carcinoma
- HNSCC:
-
Head and neck squamous cell carcinoma
- HPV:
-
Human papillomavirus
- HSA:
-
Heat stable antigen
- ICAM1:
-
Intercellular adhesion molecule 1
- MAPK:
-
Mitogen-activated protein kinases
- NOD:
-
Nonobese diabetic
- Oct3/4:
-
Octamer-binding transcription factor 3/4
- OSCC:
-
Oral squamous cell carcinoma
- P-gp:
-
P-glycoprotein
- PI3K:
-
Phosphatidylinositol-3-kinase
- POU:
-
Pit-Oct-Unc
- SCC:
-
Squamous cell carcinoma
- SCID:
-
Severe combined immunodeficiency
- SOX2:
-
Sex-determining region Y-box2
- SP:
-
Side population
References
Albrecht, C., & Viturro, E. (2007). The ABCA subfamily--gene and protein structures, functions and associated hereditary diseases. Pflügers Archiv, 453(5), 581–589.
Allegra, E., & Trapasso, S. (2012). Cancer stem cells in head and neck cancer. Oncotargets and Therapy, 5, 375–583.
Borst, P., Evers, R., Kool, M., et al. (1999). The multidrug resistance protein family. Biochimica et Biophysica Acta, 1461, 347–357.
Bourguignon, L. Y., Wong, G., Earie, C., et al. (2012). Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. The Journal of Biological Chemistry, 287(39), 32800–32824.
Bruni, L., Barrionuevo-Rosas, L., Albero, G. et al. (2017). Human papillomavirus and related diseases in South Africa. Summary Report.
Chen, Y. C., Chen, Y. W., Hsu, H. S., et al. (2009). Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochemical and Biophysical Research Communications, 385(3), 307–313.
Chen, D., Wu, M., Li, Y., et al. (2017). Targeting BMI1 + cancer stem cells overcomes Chemoresistance and inhibits metastases in squamous cell carcinoma. Cell Stem Cell, 20(5), 621–634.
Chiou, S. H., CC, Y., Huang, C. Y., et al. (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clinical Cancer Research, 14(13), 4085–4095.
Clarke, M., & Fuller, M. (2006). Stem cells and cancer: Two faces of eve. Cell, 124(6), 111–1115.
Clay, M. R., Tabor, M., Owen, J. H., et al. (2010). Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head & Neck, 23(9), 1195–1201.
Dean, M. (2009). ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology and Neoplasia, 14(1), 3–9.
Dean, M., Hamon, Y., & Chimini, G. (2001). The human ATP-binding cassette (ABC) transporter superfamily. Journal of Lipid Research, 42(7), 1007–1017.
Ding, X., Wu, J., & Jiang, C. (2010). ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sciences, 86(17–18), 631–637.
El-Naggar, A., Chan, J., & Grandis, J. (Eds). (2017). Tumours of the oropharynx (base of tongue, tonsils, adenoids). In WHO Classification of Head and Nect Tumours. IARC.
Erdei, Z., Lőrincz, R., Szebényi, K., et al. (2014). Expression pattern of the human ABC transporters in pluripotent embryonic stem cells and in their derivatives. Cytometry Part B, Clinical Cytometry, 86(5), 299–310.
Eun, K., Ham, S. W., & Kim, H. (2017). Cancer stem cell heterogeneity: Origin and new perspectives on CSC targeting. BMB Reports, 50(3), 117–125.
Eyler, C., & Rich, J. (2008). Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. Journal of Clinical Oncology, 26(17), 2839–2845.
Fábián, Á., Vereb, G., & Szöllosi, J. (2013). The hitchhikers guide to cancer stem cell theory: Markers, pathways and therapy. Cytometry. Part A, 83(1), 62–71.
Falasca, M., & Linton, K. J. (2012). Investigational ABC transporter inhibitors. Expert Opinion on Investigational Drugs, 21(5), 657–666.
Fan, Z., Li, M., Chen, X., et al. (2017). Prognostic value of cancer stem cell markers in head and neck squamous cell carcinoma: A meta-analysis. Scientific Reports, 7, 1–8.
Gil, J., Stembalska, A., Pesz, K. A., et al. (2008). Cancer stem cells: The theory and perspectives in cancer therapy. Journal of Applied Genetics, 49(2), 193–199.
Golebiewska, A., Brons, N. H., Bjerkvig, R., et al. (2011). Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell, 8(2), 136–147.
González-Moles, M. A., Scully, C., Ruiz-Ávila, I., et al. (2013). The cancer stem cell hypothesis applied to oral carcinoma. Oral Oncology, 49(8), 738–746.
Goodell, M. A., Brose, K., Paradis, G., et al. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. The Journal of Experimental Medicine, 183, 1797–1806.
Grimm, M., Krimmel, M., Polligkeit, J., et al. (2012). ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. European Journal of Cancer, 48(17), 3186–3197.
Han, J., Fujisawa, T., Husain, S. R., et al. (2014). Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. BMC Cancer, 14(1), 173–184.
Hang, D., Dong, H. C., Ning, T., et al. (2012). Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Diseases of the Esophagus, 25(7), 638–644.
Harper, L. J., Piper, K., Common, J., et al. (2007). Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. Journal of Oral Pathology & Medicine, 36(10), 594–603.
Heddleston, J. M., Li, Z., Lathia, J. D., et al. (2010). Hypoxia inducible factors in cancer stem cells. British Journal of Cancer, 102(5), 789–795.
Huls, M., Russel, F. G., & Masereeuw, R. (2009). The role of ATP binding cassette transporters in tissue defense and organ regeneration. The Journal of Pharmacology and Experimental Therapeutics, 328(1), 3–9.
Jamal-Hanjani, M., Quezada, S. A., Larkin, J., et al. (2015). Translational implications of tumor heterogeneity. Clinical Cancer Research, 21(6), 1258–1266.
Jemal, A., Bray, F., Center, M. M., et al. (2011). Global cancer statistics. CA: a Cancer Journal for Clinicians, 61(2), 69–90.
Karimnejad, K., Lindquist, N., & Lin, R. (2016). The role of cancer stem cells in head and neck squamous cell carcinoma and its clinical implications. In New aspects in molecular and cellular mechanisms of human carcinogenesis (pp. 97–113).
Kaseb, H. O., Fohrer-Ting, H., Lewis, D. W., et al. (2016). Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Experimental Cell Research, 348(1), 75–86.
Koukourakis, M. I., Giatromanolaki, A., Tsakmaki, V., et al. (2012). Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer. British Journal of Cancer, 106(5), 846–853.
Leonard, G. D., Fojo, T., & Bates, S. E. (2003). The role of ABC transporters in clinical practice. The Oncologist, 8(5), 411–424.
Li, H., Gao, Q., Guo, L., et al. (2011). The PTEN/PI3K/Akt pathway regulates stem-like cells in primary esophageal carcinoma cells. Cancer Biology & Therapy, 11(11), 950–958.
Liang, S. B., & Fu, L. W. (2017). Application of single-cell technology in cancer research. Biotechnology Advances, 35(4), 443–449.
Lin, T., Islam, O., & Heese, K. (2006). ABC transporters, neural stem cells and neurogenesis – a different perspective. Cell Research, 16, 857–871.
Mao, Q., & Unadkat, J. D. (2015). Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in drug transport—An update. The AAPS Journal, 17(1), 65–82.
Mǎrgǎritescu, C., Pirici, D., Simionescu, C., et al. (2012). The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC). Romanian Journal of Morphology and Embryology, 52, 985–993.
Méry, B., Guy, J. B., Espenel, S., et al. (2016). Targeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectives. World J Stem Cells, 8(1), 13–21.
Misra, S., Toole, B. P., & Ghatak, S. (2006). Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. The Journal of Biological Chemistry, 281(46), 34936–34941.
Modur, V., Joshi, P., Nie, D., et al. (2016). CD24 expression may play a role as a predictive indicator and a modulator of cisplatin treatment response in head and neck squamous cellular carcinoma. PLoS One. https://doi.org/10.1371/journal.pone.0156651.
Noto, Z., Yoshida, T., Okabe, M., et al. (2013). CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. Oral Oncology, 49(8), 787–795.
Okamoto, H., Fujishima, F., Nakamura, Y., et al. (2013). Significance of CD133 expression in esophageal squamous cell carcinoma. World Journal of Surgical Oncology, 11(1), 51–60.
Prince, M. E., Sivanandan, R., Kaczorowski, A., et al. (2007). Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 104(3), 973–978.
Qian, X., Tan, C., Wang, F., et al. (2016). Esophageal cancer stem cells and implications for future therapeutics. OncoTargets Ther, 9, 2247–2254.
Ren, Z. H., Zhang, C. P., & Ji, T. (2016). Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasis. Oncology Letters, 11(3), 1973–1979.
Saliba, A. E., Westermann, A. J., Gorski, S. A., et al. (2014). Single-cell RNA-seq: Advances and future challenges. Nucleic Acids Research, 42, 8845–8860.
Sato, N., Meijer, L., Skaltsounis, L., et al. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Medicine, 10(1), 55–63.
Satpute, P. S., Hazarey, V., Ahmed, R., et al. (2013). Cancer stem cells in head and neck squamous cell carcinoma: A review. Asian Pacific Journal of Cancer Prevention, 14(10), 5579–5587.
Spiegelberg, D., Kuku, G., Selvaraju, R., et al. (2014). Characterization of CD44 variant expression in head and neck squamous cell carcinomas. Tumor Biology, 35(3), 2053–2062.
Takahashi-Yanaga, F., & Kahn, M. (2010). Targeting Wnt signaling: Can we safely eradicate cancer stem cells? Clinical Cancer Research, 16(12), 3153–3162.
Toledano, I., Graff, P., Serre, A., et al. (2012). Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004-03. Radiotherapy and Oncology, 103(1), 57–62.
Torre, L. A., Bray, F., Siegel, R. L., et al. (2015). Global cancer statistics, 2012. CA: a Cancer Journal for Clinicians, 65(2), 87–108.
Tsai, L. L., CC, Y., Chang, Y. C., et al. (2011). Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 40(8), 621–628.
Tsai, S. T., Wang, P. J., Liou, N. J., et al. (2015). ICAM1 is a potential cancer stem cell marker of esophageal squamous cell carcinoma. PLoS One. https://doi.org/10.1371/journal.pone.0142834.
Valent, P., Bonnet, D., De Maria, R., et al. (2012). Cancer stem cell definitions and terminology : The devil is in the details. Nature Review Cancer, 12, 767–775.
Vallard, A., Espenel, S., & Guy, J. B. (2016). Targeting stem cells by radiation: From the biological angle to clinical aspects. World Journal Stem Cells, 8(8), 243–250.
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2009). Human ATP-binding cassette (ABC) transporter family. Human Genomics, 3(3), 281–290.
Vigneswaran, N., & Williams, D. M. (2014). Epidemiological trends in head and neck cancer and aids in diagnosis. Oral and Maxillofacial Surgery Clinics of North America, 26(2), 123–141.
Vissink, A., Mitchell, J. B., Baum, B. J., et al. (2010). Clinical management of salivary gland hypofunction and xerostomia in head and neck cancer patients: Successes and barriers. International Journal of Radiation Oncology, Biology, Physics, 78(4), 983–991.
Visvader, J. E., & Lindeman, G. J. (2012). Perspective cancer stem Cells : Current status and evolving complexities. Cell Stem Cell, 10(6), 717–728.
Vlashi, E., McBride, W., & Pajonk, F. (2009). Radiation responses of cancer stem cells. Journal of Cellular Biochemistry, 108(2), 339–342.
Wang, E., Casciano, C. N., Clement, R. P., et al. (2000). In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. Drug Metabolism and Disposition, 28(5), 522–528.
Wang, J., Guo, L. P., Chen, L. Z., et al. (2007). Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Research, 67(8), 3716–3724.
Wang, S., Wong, G., & de Heer, A. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope, 119(8), 1518–1530.
Wang, Y., Zhe, H., Zhang, N., et al. (2012). Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China. Diseases of the Esophagus, 25, 560–565.
Wicha, M., Liu, S., & Dontu, G. (2006). Cancer stem cells: An old idea – a paradigm shift. Cancer Research, 66(4), 1883–1890.
Yan, M., Yang, X., Wang, L., et al. (2013). Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Molecular & Cellular Proteomics, 12(11), 3271–3284.
Yang, M. H., Hsu, D. S., Wang, H. W., et al. (2010). Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nature Cell Biology, 12(10), 982–992.
Yaromina, A., Krause, M., Thames, H., et al. (2007). Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiotherapy and Oncology, 83(3), 304–310.
Yata, K., Beder, L., Tamagawa, S., et al. (2015). MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma. International Journal of Oncology, 47(4), 1249–1256.
Yu, C., Lo, W., Chen, Y., et al. (2010). Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. Journal of Oncology, 2011, 1–16.
Zechner, D., Fuijita, Y., Hulsken, J., et al. (2003). Beta-catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Developmental Biology, 258(2), 406–418.
Zhang, P., Zhang, Y., Mao, L., et al. (2009). Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Letters, 277(2), 227–234.
Zhang, Q., Shi, S., Yen, Y., et al. (2010). A subpopulation of CD133+ cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Letters, 289(2), 151–160.
Zhang, G., Ma, L., Xie, Y., et al. (2012a). Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity. Molecular Medicine Reports, 6(3), 519–524.
Zhang, Z., Filho, M. S. A., & Nor, J. E. (2012b). The biology of head and neck cancer stem cells. Oral Oncology, 49(1), 1–9.
Zhu, L., Yuan, L., Wang, H., et al. (2015). A meta-analysis of concurrent chemoradiotherapy for advanced esophageal cancer. PLoS One. https://doi.org/10.1371/journal.pone.0128616.
Zimmerer, R., Ludwig, N., Kampmann, A., et al. (2017). CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo. Microvascular Research, 112, 101–108.
Zscheppang, K., Kurth, I., Wachtel, N., et al. (2016). Efficacy of beta1 integrin and EGFR targeting in sphere-forming human head and neck cancer cells. Journal of Cancer, 7(6), 736–745.
Acknowledgements
This research was funded by the South African Medical Research Council in terms of the SAMRC's Flagship Award Project SAMRC-RFA-UFSP-01-2013/STEM CELLS, the SAMRC Extramural Unit for Stem Cell Research and Therapy and the Institute for Cellular and Molecular Medicine of the University of Pretoria.
Conflicts of Interest
The authors have no conflicts of interest to declare.
Author Contribution
MSP conceived the project, EW drafted the first version of the manuscript, and EW, SB, SN, AEM, and MSP provided intellectual input and contributed to the writing of the manuscript. All authors vetted and approved the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Wolmarans, E., Boy, S.C., Nel, S., Mercier, A.E., Pepper, M.S. (2017). Cancer Stem Cells in Head and Neck Carcinomas: Identification and Possible Therapeutic Implications. In: Van Pham, P. (eds) Stem Cells: Biology and Engineering. Advances in Experimental Medicine and Biology(), vol 1083. Springer, Cham. https://doi.org/10.1007/5584_2017_116
Download citation
DOI: https://doi.org/10.1007/5584_2017_116
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-77481-7
Online ISBN: 978-3-319-77482-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)